NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
106 hedge funds and large institutions have $124M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 41 increasing their positions, 38 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
59% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 27
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
106
Holding in Top 10
1
Calls
$33K
Puts
$3K
Top Buyers
| 1 | +$1.36M | |
| 2 | +$1.07M | |
| 3 | +$697K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$519K |
| 5 |
State Street
Boston,
Massachusetts
|
+$304K |
Top Sellers
| 1 | -$2.29M | |
| 2 | -$1.42M | |
| 3 | -$572K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$426K |
| 5 |
Squarepoint
New York
|
-$291K |